MedPath

Sidney Kimmel Cancer Center at Thomas Jefferson University

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

160

Active:11
Completed:101

Trial Phases

5 Phases

Early Phase 1:15
Phase 1:45
Phase 2:45
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (148 trials with phase data)• Click on a phase to view related trials

Phase 1
45 (30.4%)
Phase 2
45 (30.4%)
Not Applicable
37 (25.0%)
Early Phase 1
15 (10.1%)
Phase 3
6 (4.1%)

SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice

Not Applicable
Terminated
Conditions
Pancreatic Cancer
First Posted Date
2019-01-29
Last Posted Date
2025-04-30
Lead Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Target Recruit Count
4
Registration Number
NCT03820544
Locations
🇺🇸

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)

Not Applicable
Completed
Conditions
Lung Cancer
First Posted Date
2019-01-29
Last Posted Date
2025-04-29
Lead Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Target Recruit Count
44
Registration Number
NCT03820557
Locations
🇺🇸

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)

Completed
Conditions
Prostate Cancer
First Posted Date
2019-01-17
Last Posted Date
2025-05-15
Lead Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Target Recruit Count
241
Registration Number
NCT03807492
Locations
🇺🇸

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Phase 2
Active, not recruiting
Conditions
Stage 0 Colorectal Cancer AJCC v8
Stage I Colorectal Cancer AJCC v8
Stage IIB Colorectal Cancer AJCC v8
Stage IIIA Colorectal Cancer AJCC v8
Colorectal Adenoma
Stage II Colorectal Cancer AJCC v8
Stage IIC Colorectal Cancer AJCC v8
Stage IIIB Colorectal Cancer AJCC v8
Stage IIA Colorectal Cancer AJCC v8
Stage III Colorectal Cancer AJCC v8
Interventions
Other: Placebo
First Posted Date
2019-01-08
Last Posted Date
2025-05-15
Lead Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Target Recruit Count
230
Registration Number
NCT03796884
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

🇺🇸

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

🇺🇸

VA Puget Sound Health Care Sysem, Seattle, Washington, United States

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Phase 2
Completed
Conditions
Uveal Melanoma
First Posted Date
2018-10-19
Last Posted Date
2023-01-06
Lead Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Target Recruit Count
3
Registration Number
NCT03712904
Locations
🇺🇸

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 32
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.